Kareinen Ilona, Cedó Lídia, Silvennoinen Reija, Laurila Pirkka-Pekka, Jauhiainen Matti, Julve Josep, Blanco-Vaca Francisco, Escola-Gil Joan Carles, Kovanen Petri T, Lee-Rueckert Miriam
Wihuri Research Institute, Helsinki, Finland.
IIB Sant Pau, Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona-CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Barcelona, Spain.
J Lipid Res. 2015 Feb;56(2):241-53. doi: 10.1194/jlr.M050948. Epub 2014 Dec 3.
Reverse cholesterol transport (RCT) pathway from macrophage foam cells initiates when HDL particles cross the endothelium, enter the interstitial fluid, and induce cholesterol efflux from these cells. We injected [(3)H]cholesterol-loaded J774 macrophages into the dorsal skin of mice and measured the transfer of macrophage-derived [(3)H]cholesterol to feces [macrophage-RCT (m-RCT)]. Injection of histamine to the macrophage injection site increased locally vascular permeability, enhanced influx of intravenously administered HDL, and stimulated m-RCT from the histamine-treated site. The stimulatory effect of histamine on m-RCT was abolished by prior administration of histamine H1 receptor (H1R) antagonist pyrilamine, indicating that the histamine effect was H1R-dependent. Subcutaneous administration of two other vasoactive mediators, serotonin or bradykinin, and activation of skin mast cells to secrete histamine and other vasoactive compounds also stimulated m-RCT. None of the studied vasoactive mediators affected serum HDL levels or the cholesterol-releasing ability of J774 macrophages in culture, indicating that acceleration of m-RCT was solely due to increased availability of cholesterol acceptors in skin. We conclude that disruption of the endothelial barrier by vasoactive compounds enhances the passage of HDL into interstitial fluid and increases the rate of RCT from peripheral macrophage foam cells, which reveals a novel tissue cholesterol-regulating function of these compounds.
当高密度脂蛋白(HDL)颗粒穿过内皮、进入组织液并诱导巨噬细胞泡沫细胞发生胆固醇外流时,从巨噬细胞泡沫细胞开始的逆向胆固醇转运(RCT)途径启动。我们将负载[³H]胆固醇的J774巨噬细胞注射到小鼠背部皮肤中,并测量巨噬细胞衍生的[³H]胆固醇向粪便中的转移[巨噬细胞RCT(m-RCT)]。向巨噬细胞注射部位注射组胺可增加局部血管通透性,增强静脉注射HDL的流入,并刺激组胺处理部位的m-RCT。组胺对m-RCT的刺激作用在预先给予组胺H1受体(H1R)拮抗剂吡苄明后被消除,表明组胺的作用依赖于H1R。皮下给予另外两种血管活性介质5-羟色胺或缓激肽,以及激活皮肤肥大细胞以分泌组胺和其他血管活性化合物也刺激了m-RCT。所研究的血管活性介质均未影响血清HDL水平或培养的J774巨噬细胞的胆固醇释放能力,表明m-RCT的加速完全是由于皮肤中胆固醇受体的可用性增加。我们得出结论,血管活性化合物破坏内皮屏障可增强HDL进入组织液的过程,并增加外周巨噬细胞泡沫细胞的RCT速率,这揭示了这些化合物一种新的组织胆固醇调节功能。